NanoSphere
NanoSphere is the #1 nanomedicine science-translation platform dedicated to bridging the gap between lab research and market commercialization. Founded in July 2023, the company translates deep nanoscience into strategic insights, focusing on nano-carriers like lipid nanoparticles (LNPs), ADCs, mRNA platforms, and nucleic acid delivery systems. Built by scientists and backed by operators, NanoSphere provides curated knowledge, expert interviews, and real-time data to help innovators, researchers, investors, and policymakers move faster. They offer daily curated knowledge from academia, monthly updates on key nanomedicine components, weekly expert interviews, a monthly newsletter, and an AI-assisted content database. Based in Switzerland and supported by FONGIT, NanoSphere aims to accelerate the impact of nanomedicine across the healthcare sector.
NanoSphere
NanoSphere is the #1 nanomedicine science-translation platform dedicated to bridging the gap between lab research and market commercialization. Founded in July 2023, the company translates deep nanoscience into strategic insights, focusing on nano-carriers like lipid nanoparticles (LNPs), ADCs, mRNA platforms, and nucleic acid delivery systems. Built by scientists and backed by operators, NanoSphere provides curated knowledge, expert interviews, and real-time data to help innovators, researchers, investors, and policymakers move faster. They offer daily curated knowledge from academia, monthly updates on key nanomedicine components, weekly expert interviews, a monthly newsletter, and an AI-assisted content database. Based in Switzerland and supported by FONGIT, NanoSphere aims to accelerate the impact of nanomedicine across the healthcare sector.